The global patient monitoring devices market size was estimated at USD 54.33 billion in 2025 and is expected to reach USD 118.21 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. This significant growth can be attributed to the rising demand for advanced monitoring devices capable of measuring, recording, and displaying a wide range of biometric parameters, including blood pressure, body temperature, heart rate, respiratory rate, and blood oxygen saturation levels. Such devices play a crucial role in improving patient care by enabling timely clinical interventions, continuous health tracking, and early detection of potential complications.

A key factor driving market expansion is the growing geriatric population, coupled with the increasing prevalence of chronic health conditions such as cardiovascular diseases, diabetes, and respiratory disorders. The need for continuous and real-time monitoring is particularly critical among older adults, who are more susceptible to health complications and require close observation for effective disease management. According to the World Health Organization, by 2030, one in six people globally will be aged 60 years or older, which is expected to significantly amplify the demand for patient monitoring technologies that support timely intervention, home-based care, and remote monitoring solutions.

In addition, the rising adoption of telehealth and remote patient monitoring programs is fueling market growth. Healthcare providers are increasingly turning to connected monitoring devices to manage costs, address staffing shortages, and maintain high-quality patient care. For example, the AMA Digital Health Care 2022 study highlighted that 93% of physicians consider digital health tools to be beneficial, and the usage of remote patient monitoring (RPM) has more than doubled to 30% since 2016. This growing reliance on connected monitoring devices demonstrates strong clinician confidence in their effectiveness for managing chronic conditions, supporting post-acute recovery, and implementing preventive care strategies. Collectively, these factors underscore the expanding role of patient monitoring devices in modern healthcare delivery and their contribution to the market’s sustained growth trajectory.

Key Market Trends & Insights:

• North America dominated the global patient monitoring devices market, accounting for a 34.99% share in 2025, reflecting the region’s advanced healthcare infrastructure, high adoption of digital health technologies, and well-established hospital and clinical networks. The presence of leading medical device manufacturers, supportive regulatory frameworks, and increasing healthcare expenditure have further strengthened the region’s market leadership. In addition, rising prevalence of chronic diseases, growing geriatric population, and heightened awareness of continuous health monitoring are driving the widespread adoption of patient monitoring devices across North America, positioning it as a key revenue-generating region in the global market.

• The patient monitoring devices market in the U.S. has seen significant growth over the forecast period, driven by factors such as increasing demand for real-time monitoring solutions, expansion of telehealth programs, and the adoption of remote patient monitoring technologies in response to healthcare staffing challenges and cost containment pressures. U.S. healthcare providers are increasingly implementing connected monitoring devices to improve patient outcomes, manage chronic conditions, and enable timely intervention, which has substantially contributed to market growth.

• By product, the cardiac monitoring devices segment dominated the market with a share of 14.80% in 2025. This segment includes devices that track heart rate, electrocardiogram (ECG), arrhythmias, and other cardiac parameters, which are essential for diagnosing and managing cardiovascular diseases. The high prevalence of heart-related conditions, coupled with growing awareness about early detection and preventive care, has fueled the demand for cardiac monitoring solutions. Advancements in wearable and remote cardiac monitoring technologies have further reinforced the dominance of this segment.

• By end use, the hospitals segment accounted for the largest revenue share in 2025, reflecting hospitals’ critical role in patient care delivery and continuous monitoring. Hospitals are increasingly adopting advanced monitoring systems to manage in-patients, intensive care units, and post-operative care, ensuring timely detection of complications and improved patient outcomes. The large-scale implementation of monitoring devices in hospitals, combined with the integration of digital health platforms and telemonitoring programs, has positioned hospitals as the leading end-use segment in the patient monitoring devices market.

Order a free sample PDF of the Patient Monitoring Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2025 Market Size: USD 54.33 Billion

• 2033 Projected Market Size: USD 118.21 Billion

• CAGR (2026-2033): 10.5%

• North America: Largest market in 2025

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The patient monitoring devices market is highly fragmented, with a large number of both small and large players actively operating across different regions and healthcare segments. This fragmentation contributes to intense competition, particularly among smaller companies, as they strive to maintain their market presence, differentiate their offerings, and capture a larger share of the growing demand for monitoring solutions. The competitive environment encourages continuous innovation, driving companies to enhance the functionality, accuracy, and connectivity of their devices to meet evolving clinical and patient needs.

To stay competitive and propel market growth, key strategies such as new product launches and strategic partnerships are being widely adopted. Companies are introducing advanced devices with features such as wireless connectivity, wearable formats, remote monitoring capabilities, and integration with digital health platforms, enabling better patient management and real-time data collection. At the same time, collaborations and partnerships with hospitals, technology providers, and research institutions allow manufacturers to expand their distribution networks, accelerate product development, and improve clinical adoption. Collectively, these strategic initiatives help players strengthen their market position, increase visibility, and capitalize on the rising demand for patient monitoring devices across hospitals, clinics, and home care settings.

Key Players

• Bosch

• Biotronik

• Welch Allyn

• Koninklijke Philips N.V.

• GE Healthcare

• Medtronic

• MASIMO CORPORATION

• Smith’s Medical

• OMRON Corporation

• Mindray Medical India Pvt. Ltd.

• F. Hoffmann-La Roche Ltd 

• Drägerwerk AG & Co. KGaA

• NIHON KOHDEN CORPORATION

• Natus Medical

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global patient monitoring devices market is poised for strong expansion through the forecast period, driven by rising demand for technologies that measure and display key health metrics. Growth is supported by an aging population, increasing prevalence of chronic diseases such as cardiovascular and respiratory conditions, and a greater need for continuous and connected patient monitoring. Widespread adoption of telehealth and remote patient monitoring solutions, along with ongoing technological advancements in device connectivity and usability, are further fueling market momentum.